RIEDEL NORBERT G — SEC Form 4 filings
SEC reporting owner CIK 1161662. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-15 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,415 shares, $655,680 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 3,415 shares @ $192.00 ($655,680) in Jazz Pharmaceuticals plc, filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | 5 | — | 1 leg · 3,415 sh · $655,680 | 9 |
| Eton Pharmaceuticals, Inc. (ETON) | Director | 7 | — | — | 17 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | Director | 2 | — | — | 4 |
Form 4 filings — RIEDEL NORBERT G
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 14 @ $244.64 · Tax withholding (F): 1,692 @ $241.39 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-04 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise (M): 12,500 @ $7.31 · Option exercise (M): 19,655 @ $8.61 · Option exercise (M): 12,500 (derivative) @ $0 · Option exercise (M): 19,655 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 3,415 @ $138.08 · Sale (S): 3,415 @ $192 · Option exercise (M): 3,415 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise/expiry (X): 30,000 @ $4.42 · Option exercise/expiry (X): 30,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 12,196 (derivative) @ $0 · Grant/award (A): 7,757 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,507 @ $0 · Tax withholding (F): 1,805 @ $111.25 | EDGAR |
| 2025-01-06 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise (M): 27,400 @ $3.58 · Option exercise (M): 50,000 @ $3.78 · Option exercise (M): 25,000 @ $3.47 · Option exercise (M): 27,400 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,731 @ $0 · Tax withholding (F): 1,484 @ $111.35 | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 46,092 · Disposition to issuer (D): 10,461 · Disposition to issuer (D): 95,242 (derivative) | EDGAR |
| 2024-06-07 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 10,461 | EDGAR |
| 2024-02-15 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1161662 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →